About 20% of FALS have a SOD1 mutation.4 The identification of SOD1 mutations in ALS has allowed the development of animal models of the disease to study molecular pathogenic events in vivo and to study drug survival effects and improvements of pathology. Here, SOD1 is linked to amyotrophic lateral sclerosis.